October Pharma S.A.E (EGX:OCPH)

Market Cap	1.80B
Revenue (ttm)	1.34B
Net Income (ttm)	138.41M
Shares Out	12.00M
EPS (ttm)	11.53
PE Ratio	13.04
Forward PE	n/a
Dividend	2.50 (1.66%)
Ex-Dividend Date	n/a

Volume	34,435
Average Volume	5,441
Open	125.34
Previous Close	125.34
Day's Range	126.00 - 150.40
52-Week Range	85.04 - 166.99
Beta	0.13
RSI	82.29
Earnings Date	Aug 14, 2025

About October Pharma S.A.E

October Pharma S.A.E manufactures and sells pharmaceutical products in Egypt. The company provides its products in solid forms, such as tablets, capsules, and powders; liquid forms comprising syrups, drops, solutions, and sprays; creams and suppositories; soft gelatin capsules; and ampoules and vials. October Pharma S.A.E was founded in 1987 is based in Cairo, Egypt.

• Industry: Pharmaceutical Preparations
• Founded: 1987
• Country: Egypt
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: OCPH

Financial Performance

In 2024, October Pharma S.A.E's revenue was 1.23 billion, an increase of 21.39% compared to the previous year's 1.01 billion. Earnings were 131.26 million, a decrease of -12.72%.